| Heading: |
Animal Experiments |
| Question ID: |
1812063 |
| UIN: |
59430 |
| House: |
Commons |
| Date tabled: |
2025-06-12 |
| Asking Member ID: |
5089 |
| Asking Member display name: |
Ben Obese-Jecty
|
| Asking Member handle: |
BenObeseJecty
|
| Asking Member Twitter reference: |
@BenObeseJecty
|
| Member interest: |
false |
| Question text: |
To ask the Secretary of State for Science, Innovation and Technology, what assessment he has made of the implications for his Department’s policies of the document by the Food and Drug Administration entitled Roadmap to Reducing Animal Testing in Preclini |
| Is named day: |
false |
| Date of holding answer: |
|
| Date answered: |
2025-06-20 |
| Date answer corrected: |
|
| Is holding answer: |
false |
| Is correcting answer: |
false |
| Answering Member ID: |
4822 |
| Answering Member display name: |
Feryal Clark
|
| Answering Member handle: |
FeryalClark
|
| Answering Member Twitter reference: |
@FeryalClark
|
| Correcting Member ID: |
|
| Correcting Member display name: |
|
| Correcting Member handle: |
|
| Correcting Member Twitter reference: |
|
| Answer text: |
The Government has reviewed the FDA roadmap and is engaging with the MHRA on how to accelerate the science-led adoption of alternatives to the use of animals for drug development and testing. The Government will publish a strategy later this year that wil... |
| Original answer text: |
|
| Comparable answer text: |
|
| Answering body ID: |
216 |
| Answering body name: |
Department for Science, Innovation and Technology |
| Tweeted: |
true |